Johnson & Johnson

Stories 1 - 20 |  Next >>

Johnson & Johnson's 'No-Brainer' Fix on Baby Powder

Cornstarch will take its place, starting next year, after complaints talc caused cancer

(Newser) - You already won't find Johnson & Johnson baby powder containing talc on most store shelves in the US and Canada, but now the company is nixing the ingredient in that product worldwide, after tens of thousands of complaints were filed alleging it caused cancer in consumers who used it....

FDA Limits Authorized Use of Johnson & Johnson Vaccine

If they can, adults should get Moderna or Pfizer coronavirus shots, agency says

(Newser) - Referring to new data on blood clots, the Food and Drug Administration announced limits Thursday on who should and should not be administered Johnson & Johnson's coronavirus vaccine. Only adults unable to receive other vaccines instead, either because the products are inaccessible or they're not clinically appropriate, are...

J&J Is Pausing COVID Vaccine Production

Move is said to be temporary, but some are raising concerns

(Newser) - The only Johnson & Johnson plant that had been making usable batches of the company's COVID-19 vaccine is no longer producing it, a move that could reduce the global supply of the vaccine by a few hundred million doses, sources tell the New York Times . J&J quietly made...

CDC Panel Backs Other Vaccines Over J&J's
Get Pfizer or
Not J&J

CDC: Get Pfizer or Moderna, Not J&J

CDC makes official new recommendation

(Newser) - Update: The CDC is now officially taking the stance that that "mRNA vaccines are preferred over [Johnson & Johnson's] Janssen COVID-19 vaccine for the prevention of COVID-19 for those 18 years of age and over." Within hours of a panel making that recommendation, the CDC director accepted...

Supreme Court Delivers Blow to J&J Over Baby Powder

Justices let suit brought by Mississippi over health risks proceed

(Newser) - The Supreme Court on Monday turned away a request by Johnson & Johnson to halt a Mississippi lawsuit over its talcum powder products, per the AP . As is typical, the high court didn't say anything in turning away the case, which was included in a long list of cases...

2 More Conglomerates Are Breaking Up

J&J, Toshiba announce plans to separate their businesses in coming years

(Newser) - Johnson & Johnson plans to split into two publicly traded companies. And in case you're wondering, no, they won't be called "Johnson I" and "Johnson II." Johnson & Johnson will keep its name and its title as the world's largest health-products company by sales...

Court Overturns $465M Opioid Ruling Against Johnson & Johnson

It's the second blow to a case like this in the past month

(Newser) - The Oklahoma Supreme Court on Tuesday overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state's public nuisance law in the first case of its kind in the US to go to trial. The ruling was the second blow...

Booster Shots Are Expected to Start Going in Arms Today

CDC, Walensky gave final approval Thursday night

(Newser) - Update: An advisory panel unanimously recommended to the Centers for Disease Control and Prevention on Thursday that coronavirus vaccine booster shots be approved. Tens of millions of people would be eligible for the doses, which the FDA backed the day before, the Washington Post reports. (There's an explainer on...

S&P 500 Closes in on Record High
First Bitcoin ETF
Jumps 4.8% in Market Debut

First Bitcoin ETF Jumps 4.8% in Market Debut

S&P 500 is closing in on record high

(Newser) - Stocks closed higher on Wall Street Tuesday, giving the S&P 500 its fifth straight gain and getting it closer to the record high it set in early September. The Dow Jones Industrial Average and the Nasdaq also closed higher. Health care companies made some of the biggest gains. Johnson...

J&J Could've Been 2 Shots All Along, Fauci Says

Booster recipients probably will be able to mix brands

(Newser) - In hindsight, the Johnson & Johnson coronavirus vaccine probably should have been two shots from the start, as other vaccines are, Dr. Anthony Fauci said Sunday. Asked on ABC's This Week whether people who received the company's single dose should be alarmed because an FDA advisory panel has...

FDA Panel Endorses J&J Booster Shot
FDA Panel Endorses
J&J Booster Shot

FDA Panel Endorses J&J Booster Shot

Advisers set no timeline but says shot should come at least 2 months after the first one

(Newser) - A panel of US health advisers endorsed booster doses of Johnson & Johnson's single-shot COVID-19 vaccine Friday, saying they should be offered at least two months after immunization. J&J has asked the Food and Drug Administration for flexibility with its booster, the AP reports, arguing that the extra...

FDA Report Is Inconclusive on Johnson & Johnson Booster

Outside advisers are meeting this week to consider approval and interval

(Newser) - It's not clear yet whether people who received the one-shot Johnson & Johnson coronavirus vaccine will be cleared to get a booster shot or will be told to switch brands. A Food and Drug Administration staff report released Wednesday said that there's evidence the J&J booster strengthened...

J&J: Our Booster Shot Works
J&J: Shot No. 2 Works

J&J: Shot No. 2 Works

Company's data has not been peer-reviewed, but this is a first step

(Newser) - Johnson & Johnson released data showing that a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose, per the AP . J&J said in statement Tuesday that it ran two early studies in people previously given its vaccine and found...

J&J Shuts Down HIV Vaccine Trial
J&J Shuts Down 
HIV Vaccine Trial

J&J Shuts Down HIV Vaccine Trial

Study in five African countries found that it only provided 25% protection

(Newser) - Scientists searching for an HIV vaccine have been disappointed yet again. Johnson & Johnson says it has shut down a vaccine trial in Africa that started in 2017 after finding that it only provided 25% protection, the New York Times reports. The trial involved young women at high risk of...

Johnson & Johnson: Booster Pumps Up Antibodies Big Time

Company says booster at least 6 months later caused bigger spike in antibodies than first shot

(Newser) - The Pfizer vaccine now known as Comirnaty has received full approval from the Food and Drug Administration, paving the way for booster shots. Moderna's full OK from the FDA is said to be just a few weeks away, and now Johnson & Johnson announced Wednesday that people who received...

State AGs Announce Landmark $26B Opioid Settlement

J&J, drug distributors have agreed to nationwide settlement

(Newser) - Four major drug companies have agreed to a landmark $26 billion settlement to resolve thousands of lawsuits from state and local governments over the opioid crisis, a coalition of state attorneys general announced Wednesday. The proposal calls for drugmaker Johnson & Johnson to pay $5 billion over nine years and...

Johnson & Johnson Sunscreen Recall Affects 5 Products

Consumers advised to stop using these Neutrogena, Aveeno aerosol sunscreens

(Newser) - Check your sunscreen bottles: Johnson & Johnson is recalling five of its products due to the presence of benzene, a chemical known to cause cancer. The voluntary recall affects all can sizes and SPF levels of Aveeno Protect + Refresh aerosol sunscreen plus four Neutrogena sunscreens: Beach Defense aerosol sunscreen,...

Report: FDA to Issue New Warning on J&J Vaccine
FDA Issues
New Warning
on J&J Vaccine

FDA Issues New Warning on J&J Vaccine

CDC says it has been linked to around 100 cases of Guillain-Barre syndrome

(Newser) - Another setback for the Johnson & Johnson COVID vaccine: The FDA has added a new warning to on the one-shot vaccine after reports of a rare side effect. The CDC says there have been around 100 reports of people contracting Guillain-Barre syndrome after receiving the J&J vaccine. Most of...

Johnson & Johnson Settles For $230M, Quits Opioid Business

Deal takes the pharmaceutical giant out of huge New York trial

(Newser) - Johnson & Johnson is going out of the opioid business in the US. It's also going to pay the state of New York a $230 million settlement, the New York Times reports. The agreement takes them out of a trial of several pharmaceutical makers slated to start next week....

FDA Solves Problem of Expiring Vaccines

Doses will be considered good for 4.5 months now, up from 3

(Newser) - State health officials have been nervous about hundreds of thousands of doses of Johnson & Johnson coronavirus vaccine scheduled to expire in June. It's not an issue anymore. The Food and Drug Administration told the company Thursday to consider the shelf life of the product to be 4½ months,...

Stories 1 - 20 |  Next >>
We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.